Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter
Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results
Categories
Health Care
Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023. Revenue was
Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today. Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3%
Gilead Sciences reports Q3 earnings. Here’s everything you need to know
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of 2023. Revenues
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also
Earnings Summary: Highlights of IDEXX Laboratories’ Q3 2023 earnings
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of 2023. The
REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third quarter of
Main highlights from Eli Lilly’s (LLY) Q3 2023 earnings results
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37% compared to
Cigna Group (CI) Q3 2023 Earnings: Key financials and quarterly highlights
The Cigna Group (NYSE: CI) reported third quarter 2023 earnings results today. Total revenues increased 8% to $49 billion compared to the same
Earnings Summary: A snapshot of IQVIA Holdings’ Q3 2023 results
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
CVS Health (CVS) Q3 2023 Earnings: Key financials and quarterly highlights
CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion. Net income
Key takeaways from Pfizer’s (PFE) Q3 2023 earnings results
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday, after the company delivered lackluster results for the third quarter of 2023.
AMGN Earnings: Highlights of Amgen’s Q3 2023 financial results
Biotechnology firm Amgen Inc. (NASDAQ: AMGN) on Tuesday reported higher revenues and adjusted earnings for the third quarter of 2023. The company
PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2023 financial results
Pfizer Inc. (NYSE: PFE) reported third quarter 2023 earnings results today. Revenues declined 42% year-over-year to $13.2 billion. The company reported a
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance
Merck (MRK) Earnings: 3Q23 Key Numbers
Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year
ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The company reported
Key highlights from Thermo Fisher’s (TMO) Q3 2023 earnings results
Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2023 earnings results today. Revenue dropped 1% year-over-year to $10.57 billion. Organic revenues